Affimed has decided to focus on testing AFM13 in combination with Artiva's AB-101 NK cell product for the treatment of peripheral T-cell lymphoma after underwhelming monotherapy data. Peripheral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback